NLRP3 and diabetic kidney disease: For instance, it was reported that AMPK activation can suppress NLRP3 overactivity and decrease inflammatory cytokines such as IL1β, IL6, IL18, and TNF-α in a mouse model of diabetic nephropathy [131, 132].